Article
Cancer-specific mutations in PIK3CA are oncogenic in vivo.
Proceedings of the National Academy of Sciences of the United States of America - 31 Jan 2006
Bader Andreas G, Kang Sohye, Vogt Peter K
Abstract excerpt
The PIK3CA gene, coding for the catalytic subunit p110alpha of class IA phosphatidylinositol 3-kinases (PI3Ks), is frequently mutated in human cancer. Mutated p110alpha proteins show a gain of enzymatic function in vitro and are oncogenic in cell culture. Here, we show that three prevalent mutants of p110alpha, E542K, E545K, and H1047R, are oncogenic in vivo. They induce tumors in the chorioallantoic membrane of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
